Taking into account that the same combinative treatment also reduced the levels of all major HSPs and also GRP78 and GRP94, while killing cancer cells and CSC-like cells [100], one can wonder why this remarkable (in all respects) combination is so far not adopted for cancer treatment. The gene discussed is HSPA5; the disease is cancer.